176 related articles for article (PubMed ID: 33398264)
1. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
Res Sq; 2020 Dec; ():. PubMed ID: 33398264
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
Nature; 2021 Jul; 595(7867):421-425. PubMed ID: 34030176
[TBL] [Abstract][Full Text] [Related]
3. Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination.
Kim W; Zhou JQ; Sturtz AJ; Horvath SC; Schmitz AJ; Lei T; Kalaidina E; Thapa M; Alsoussi WB; Haile A; Klebert MK; Suessen T; Parra-Rodriguez L; Mudd PA; Middleton WD; Teefey SA; Pusic I; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
bioRxiv; 2021 Nov; ():. PubMed ID: 34751268
[TBL] [Abstract][Full Text] [Related]
4. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
Ogega CO; Skinner NE; Blair PW; Park HS; Littlefield K; Ganesan A; Dhakal S; Ladiwala P; Antar AA; Ray SC; Betenbaugh MJ; Pekosz A; Klein SL; Manabe YC; Cox AL; Bailey JR
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571162
[TBL] [Abstract][Full Text] [Related]
5. Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination.
Astakhova EA; Byazrova MG; Yusubalieva GM; Kulemzin SV; Kruglova NA; Prilipov AG; Baklaushev VP; Gorchakov AA; Taranin AV; Filatov AV
Cells; 2022 Jun; 11(13):. PubMed ID: 35805076
[TBL] [Abstract][Full Text] [Related]
6. Persistent but atypical germinal center reaction among 3
Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Chen Y; Meisel C; Jahrsdörfer B; Ludwig C; Schrezenmeier H; Lino AC; Dörner T
Front Immunol; 2022; 13():943476. PubMed ID: 36032111
[TBL] [Abstract][Full Text] [Related]
7. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
Hellerstein M
Vaccine X; 2020 Dec; 6():100076. PubMed ID: 32875286
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
10. Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination.
Haralambieva IH; Monroe JM; Ovsyannikova IG; Grill DE; Poland GA; Kennedy RB
J Infect Dis; 2022 Aug; 226(1):23-31. PubMed ID: 35137144
[TBL] [Abstract][Full Text] [Related]
11. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andréll J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarström L; Baldanti F; Marcotte H; Pan-Hammarström Q
Med; 2021 Mar; 2(3):281-295.e4. PubMed ID: 33589885
[TBL] [Abstract][Full Text] [Related]
12. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
Quinti I; Locatelli F; Carsetti R
Front Immunol; 2021; 12():815404. PubMed ID: 35126372
[TBL] [Abstract][Full Text] [Related]
13. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
Nguyen DC; Hentenaar IT; Morrison-Porter A; Solano D; Haddad NS; Castrillon C; Lamothe PA; Andrews J; Roberts D; Lonial S; Sanz I; Lee FE
medRxiv; 2024 Mar; ():. PubMed ID: 38496525
[TBL] [Abstract][Full Text] [Related]
14. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
Lee F; Nguyen D; Hentenaar I; Morrison-Porter A; Solano D; Haddad N; Castrillon C; Lamothe P; Andrews J; Roberts D; Lonial S; Sanz I
Res Sq; 2024 Mar; ():. PubMed ID: 38559048
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
[TBL] [Abstract][Full Text] [Related]
16. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Observation of Immune Response for 23 Months in COVID-19 Convalescent Patients After Infection and Vaccination.
Xu J; Zheng J; Tan Y; Cai J; Xiang Y; Ling H; Li Z; Bai Q
Viral Immunol; 2023; 36(6):389-400. PubMed ID: 37276049
[TBL] [Abstract][Full Text] [Related]
18. The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.
Geisen UM; Rose R; Neumann F; Ciripoi M; Vullriede L; Reid HM; Berner DK; Bertoglio F; Hoff P; Hust M; Longardt AC; Lorentz T; Martini GR; Saggau C; Schirmer JH; Schubert M; Sümbül M; Tran F; Voß M; Zeuner R; Morrison PJ; Bacher P; Fickenscher H; Gerdes S; Peipp M; Schreiber S; Krumbholz A; Hoyer BF
J Med Virol; 2022 Dec; 94(12):5780-5789. PubMed ID: 35945627
[TBL] [Abstract][Full Text] [Related]
19. Detection of specific RBD
Del Pino Molina L; Bravo Gallego LY; Nozal P; Soto-Serrano Y; Martínez-Feito A; Reche-Yebra K; González-Torbay A; Cuesta-Martín de la Cámara R; Gianelli C; Cámara C; González-García J; González-Muñoz M; Rodríguez-Pena R; López Granados E
Front Immunol; 2023; 14():1136308. PubMed ID: 37215146
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
